Home
Conditions
Gram-Negative Bacterial Infections

Clinical trial condition

Gram-Negative Bacterial Infections

Explore clinical trials studying Gram-Negative Bacterial Infections. Study availability and eligibility vary by location and protocol.

1,462 public trials 132 recruiting studies

Refine in advanced search Browse all conditions

Gram-Negative Bacterial Infections trial results

Completed

Study of a Booster Dose of Hib-MenC Conjugate Vaccine vs Infanrix Hexa When Given to 14 Month Old Subjects

NCT00323050

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
Locations: GSK Investigational Site Alcorcón, Spain

GSK Investigational Site Almeira, Spain

GSK Investigational Site Barcelona, Spain

GSK Investigational Site Barcelona, Spain

View all 16 locations

View Trial Details

Completed

Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT Vaccine and Hib-MenC-TT Vaccine in Infants

NCT00135486

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: Not specified

View Trial Details

Completed

Study on Seroprevalence and Risk Factors of Coxiella Burnetii (Q Fever) in the South of Reunion Island

NCT02898402

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +2 more
Locations: Not specified

View Trial Details

Completed

Immunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix™-HepB/Hib2.5 Compared to GSK Vaccine Tritanrix™-HepB/Hiberix™

NCT01061541

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
Locations: GSK Investigational Site City of Muntinlupa, Philippines

View Trial Details

Completed

A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine

NCT00109330

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +12 more
Locations: GSK Investigational Site Mesa, Arizona, United States

GSK Investigational Site Tempe, Arizona, United States

GSK Investigational Site Jonesboro, Arkansas, United States

GSK Investigational Site Little Rock, Arkansas, United States

View all 44 locations

View Trial Details

Completed

Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity

NCT00197249

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Digestive System Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.

NCT00317174

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
Locations: GSK Investigational Site City of Muntinlupa, Philippines

View Trial Details

Completed

Persistent Lyme Empiric Antibiotic Study Europe

NCT01207739

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Borrelia Infection, +7 more
Locations: Radboud University Nijmegen Medical Centre Nijmegen, Netherlands

Sint Maartenskliniek Nijmegen, Netherlands

View Trial Details

Completed

Study to Evaluate Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 18-25 Years

NCT00196950

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: GSK Investigational Site Gosselies, Belgium

View Trial Details

Completed

Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis

NCT00633191

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: Cystic fibrosis centre,Children´s University Hospital Uppsala, Sweden

View Trial Details

Gram-Negative Bacterial Infections

Gram-Negative Bacterial Infections trial results

Related conditions